News | January 04, 2011

FDA Forecasts Medical Device Technology Trends for Next Decade

January 4, 2010 – The U.S. Food and Drug Administration (FDA) has released an update of what medical devices it expects to be developed and brought to market within the next 10 years.

The FDA this week released its “Future Trends in Medical Device Technologies” from the William A. Herman and Gilbert B. Devey Center for Devices and Radiological Health (CDRH). The forecast reflects the inputs of many participants, including senior CDRH technical managers and 15 non-FDA experts, including physicians, engineers, healthcare policymakers, manufacturers and technology analysts.

The study found the following technologies have a high likelihood of being developed and making it to market in the next decade:

Computerized devices and medical IT systems
- Integrated electronic patient medical records
- Computer-assisted diagnostic systems
- Internet-based medical device systems
- Virtual reality systems for immersive training and other applications
- Networks and systems of devices

Robotic products and systems
- Robotic surgical systems
- Robotic prosthetics

Wireless products and systems
- Advanced radiofrequency identification (RFID) systems

Artificial organs and organ-assistive products
- Tissue engineered products
- Neuro-sensory devices
- Glucose monitoring products
- Electrostimulation products
- New types of insulin pumps and delivery systems
- Advanced prosthetic limbs
- New types of stents
- Joint replacements

Combination device and drug/biological products
- New (non-eluting) drug delivery systems

Imaging devices and systems
- Image-guided therapy systems
- Advanced ultrasound imaging systems
- Advanced optical imaging systems
- Advanced magnetic resonance (MR) imaging systems

Photonic products
- Optical diagnostic products
- Optical therapeutic devices

Minimally invasive therapeutic products
- Minimally invasive implants (e.g., percutaneous or natural orifice delivery)
- Minimally invasive radiotherapy systems

Home- and self-care products
- New types of home sensors
- Smart homes

Aging-related products

Genomic, proteomic, metabolomic, and epigenomic technologies
- Genetic diagnostic products

Sensor technologies
- New sensors

Patient monitoring systems
- Remote patient monitoring systems

Other
- Point-of-care products
- MEMS/MOTES devices

The primary purpose of the forecast is to help CDRH (and other medical device stakeholders) prepare for pioneering products that will pose new scientific questions and regulatory issues during the next decade. This preview it provides is intended to help CDRH develop initiatives to identify key scientific issues, collect basic information and set clear regulatory strategies for responding to a flow of new products. To these ends, the forecast identifies emerging medical device technologies and types of devices that manufacturers are highly likely to submit to CDRH for premarket decision making.

For a copy of the complete report: www.fda.gov/downloads/AboutFDA/CentersOffices/CDRH/CDRHReports/UCM238527...

Related Content

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

News | Artificial Intelligence | February 13, 2020
February 13, 2020 — The U.S.
Hyperfine Research, Inc. announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the world’s first bedside Magnetic Resonance Imaging (MRI) system

Hyperfine's point-of-care MRI wheels directly to the patient’s bedside, plugs into a standard electrical wall outlet, and is controlled via a wireless tablet. Photo courtesy of Business Wire

News | Magnetic Resonance Imaging (MRI) | February 12, 2020
February 12, 2020 — Hyperfine Research, Inc. announced that i
The magnetic resonance imaging (MRI) contrast agents market is expected to grow rapidly

Image courtesy of GE Healthcare

News | Magnetic Resonance Imaging (MRI) | February 11, 2020
February 11, 2020 — The magnetic resonance imaging (MRI) contrast agents market is expected to grow rapidly in the fo
Gadolinium-based contrast agents

UT Dallas faculty members who collaborated with Dr. Jeremiah Gassensmith (center, back), associate professor of chemistry and biochemistry, include Dr. Lloyd Lumata (left, back), assistant professor of physics, and Dr. Steven Nielsen, associate professor of chemistry. Chemistry graduate students in Gassensmith’s lab include (from left, front) Oliva Brohlin, Arezoo Shahrivarkevishahi and Laurel Hagge.

News | Contrast Media | February 06, 2020
February 6, 2020 — University of Texas at Dallas researchers
Qynapse, a medical technology company, announced that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its QyScore software
News | Information Technology | February 04, 2020
February 4, 2020 — Qynapse, a medical technology company, anno
RSNA 2019

RSNA 2019

Feature | Radiology Imaging | January 31, 2020 | By Greg Freiherr
The founder of Gonzo journalism thought
This image is of an 80 kg woman with a newly diagnosed IDH-wildtype glioblastoma

This image is of an 80 kg woman with a newly diagnosed IDH-wildtype glioblastoma. The quarter dose image on the left was obtained after the administration of 4 ml of MultiHance. Subsequently, an additional 12 ml of MultiHance was administered and the cumulative full dose image in the center was obtained. The image on the right was rendered following artificial intelligence processing of the 4 ml image using eGad genetic algorithms. This image has the quality of triple dose gadolinium even though only one quarter dose gadolinium was given.

Feature | Contrast Media Injectors | January 30, 2020 | By Matthew Kuhn, M.D., FACR
Gadolinium-based contrast agents (...
Automated Triage of Thyroid Cancer

73-year-old man with papillary carcinoma of left lobe of thyroid. Screen shot shows example of thyroid nodule annotation (segmentation and TI-RADS annotation) performed on ultrasound image in longitudinal projection with electronic Physician Annotation Device software (Stanford Medicine Radiology). Radiologists performed nodule segmentation by selecting points (red) on nodule outline (green), while controlling smoothing of outline polygon by means of spline interpolation.

News | Ultrasound Imaging | January 30, 2020
January 30, 2020 — According to an ar...
The researchers used high resolution cross-sectional imaging with CT or MRI to assess 225 men with abdominal aortic aneurysm. Follow-up lasted, on average, more than three years.  Slightly more than half of patients had an intraluminal thrombus. The aneurysms of those with intraluminal thrombus were larger at baseline and grew by a rate of 2 mm per year, twice as fast as the 1 mm per year growth rate in people without intraluminal thrombus.
News | Computed Tomography (CT) | January 29, 2020
January 29, 2020 – The presence of a blood clot on the wall of the aorta in people with...
This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.   #RSNA #

This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.

Feature | RSNA | January 20, 2020 | Dave Fornell, Editor
Here are images of some of the newest new medical imaging technologies displayed on the expo floor at the ...